Last update 13 May 2025

Inactivated EBV-infected vaccine(NCI)

Overview

Basic Info

Drug Type
Inactivated vaccine, Therapeutic vaccine
Synonyms-
Target-
Action
stimulants
Mechanism
Immunostimulants
Therapeutic Areas
Immune System DiseasesHemic and Lymphatic DiseasesOther Diseases
Active Indication-
Inactive Indication
Post-transplant lymphoproliferative disorder
Originator Organization
National Cancer InstituteNational Cancer Institute
Active Organization-
Inactive Organization
The Sidney Kimmel Comprehensive Cancer Center
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Inactivated EBV-infected vaccine(NCI)
NCT00278200
/ TerminatedPhase 1IIT
Vaccination of Patients at High Risk for Post-Transplant Lymphoproliferative Disorder With a Photochemically Inactivated EBV-Infected B-Cell Vaccine
100 Clinical Results associated with Inactivated EBV-infected vaccine(NCI)
Login to view more data
100 Translational Medicine associated with Inactivated EBV-infected vaccine(NCI)
Login to view more data
100 Patents (Medical) associated with Inactivated EBV-infected vaccine(NCI)
Login to view more data
100 Deals associated with Inactivated EBV-infected vaccine(NCI)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Post-transplant lymphoproliferative disorderPhase 1
United States
The Sidney Kimmel Comprehensive Cancer Center
01 Jan 2003
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT00278200 (CTgov)
Phase 1
Post-transplant lymphoproliferative disorder
23
(EBV Seronegative)
yqmijmbdnr = qiznjxlsma guthmzjble (vmitujwhrg, agubcwvmzo - vuwdahdpgo)
View more
-
26 Feb 2019
(EBV Seropositive)
yqmijmbdnr = wyvmchpktb guthmzjble (vmitujwhrg, ogmnosuadh - zcojlvlpvl)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free